Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beneficient (BENF) Cash & Equivalents (2022 - 2025)

Beneficient's Cash & Equivalents history spans 4 years, with the latest figure at $7.9 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 89.61% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 89.61% increase, with the full-year FY2025 number at $1.3 million, down 82.99% from a year prior.
  • Cash & Equivalents hit $7.9 million in Q4 2025 for Beneficient, up from $4.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BENF hit a ceiling of $70.6 million in Q1 2022 and a floor of $1.3 million in Q1 2025.
  • Historically, Cash & Equivalents has averaged $10.7 million across 4 years, with a median of $4.9 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: tumbled 87.64% in 2023 and later soared 89.61% in 2025.
  • Tracing BENF's Cash & Equivalents over 4 years: stood at $70.6 million in 2022, then tumbled by 84.13% to $11.2 million in 2023, then tumbled by 62.96% to $4.1 million in 2024, then soared by 89.61% to $7.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for BENF at $7.9 million in Q4 2025, $4.9 million in Q3 2025, and $7.6 million in Q2 2025.